Viewing Study NCT03355768

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-02-26 @ 2:17 AM
Study NCT ID: NCT03355768
Status: WITHDRAWN
Last Update Posted: 2018-12-19
First Post: 2017-11-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL
Sponsor: Jennifer Amengual
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, T-Cell, Peripheral View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Romidepsin View
None Pralatrexate View
None PTCL View
None Peripheral T-cell Lymphoma View